Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2018

  • ID: 4516540
  • Report
  • Region: Global
  • Fore Pharma
1 of 3
The researcher announced the results of its Prostate Cancer patients study in a new research ‘Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2018’. The research provides insights into Prostate Cancer epidemiology, Prostate Cancer diagnosed patients, and Prostate Cancer treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Prostate Cancer derived from epidemiological analysis, patients diagnosed with Prostate Cancer, and patients treated with a drug therapy.

The research study helps executives estimate Prostate Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Prostate Cancer prevalence, Prostate Cancer diagnosis rate, and Prostate Cancer treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report:
  • Prostate Cancer Patient Flow
  • Prostate Cancer Prevalence
  • Prostate Cancer Diagnosed Patients
  • Prostate Cancer Treated Patients
Note: Product cover images may vary from those shown
2 of 3
1. Prostate Cancer: Disease Definition
2. Global Prostate Cancer Patient Flow
2A. Global Prostate Cancer Prevalence
2B. Global Prostate Cancer Diagnosed Patients
2C. Global Prostate Cancer Treated Patients
3. Prostate Cancer Patient Flow in the US
3A. Prostate Cancer Prevalence in the US
3B. Prostate Cancer Diagnosed Patients in the US
3C. Prostate Cancer Treated Patients in the US
4. Prostate Cancer Patient Flow in Europe
4A. Prostate Cancer Prevalence in Europe
4B. Prostate Cancer Diagnosed Patients in Europe
4C. Prostate Cancer Treated Patients in Europe
5. Prostate Cancer Patient Flow in Germany
5A. Prostate Cancer Prevalence in Germany
5B. Prostate Cancer Diagnosed Patients in Germany
5C. Prostate Cancer Treated Patients in Germany
6. Prostate Cancer Patient Flow in France
6A. Prostate Cancer Prevalence in France
6B. Prostate Cancer Diagnosed Patients in France
6C. Prostate Cancer Treated Patients in France
7. Prostate Cancer Patient Flow in Spain
7A. Prostate Cancer Prevalence in Spain
7B. Prostate Cancer Diagnosed Patients in Spain
7C. Prostate Cancer Treated Patients in Spain
8. Prostate Cancer Patient Flow in Italy
8A. Prostate Cancer Prevalence in Italy
8B. Prostate Cancer Diagnosed Patients in Italy
8C. Prostate Cancer Treated Patients in Italy
9. Prostate Cancer Patient Flow in UK
9A. Prostate Cancer Prevalence in UK
9B. Prostate Cancer Diagnosed Patients in UK
9C. Prostate Cancer Treated Patients in UK
10. Prostate Cancer Patient Flow in Japan
10A. Prostate Cancer Prevalence in Japan
10B. Prostate Cancer Diagnosed Patients in Japan
10C. Prostate Cancer Treated Patients in Japan
11. Research Methodology

List of Tables
Table 1: Global Prostate Cancer Patient Flow, 2017
Table 2: Global Prostate Cancer Patient Flow Forecast, 2017 - 2026
Table 3: Prostate Cancer Patient Flow in the US, 2017
Table 4: Prostate Cancer Patient Flow Forecast in the US, 2017 - 2026
Table 5: Prostate Cancer Patient Flow in Europe, 2017
Table 6: Prostate Cancer Patient Flow Forecast in Europe, 2017 - 2026
Table 7: Prostate Cancer Patient Flow in Germany, 2017
Table 8: Prostate Cancer Patient Flow Forecast in Germany, 2017 - 2026
Table 9: Prostate Cancer Patient Flow in France, 2017
Table 10: Prostate Cancer Patient Flow Forecast in France, 2017 - 2026
Table 11: Prostate Cancer Patient Flow in Spain, 2017
Table 12: Prostate Cancer Patient Flow Forecast in Spain, 2017 - 2026
Table 13: Prostate Cancer Patient Flow in Italy, 2017
Table 14: Prostate Cancer Patient Flow Forecast in Italy, 2017 - 2026
Table 15: Prostate Cancer Patient Flow in UK, 2017
Table 16: Prostate Cancer Patient Flow Forecast in UK, 2017 - 2026
Table 17: Prostate Cancer Patient Flow in Japan, 2017
Table 18: Prostate Cancer Patient Flow Forecast in Japan, 2017 - 2026

List of Figures
Figures 1: Global Prostate Cancer Patient Flow, 2017
Figure 2: Global Prostate Cancer Patient Flow Forecast, 2017 - 2026
Figure 3: Prostate Cancer Patient Flow in the US, 2017
Figure 4: Prostate Cancer Patient Flow Forecast in the US, 2017 - 2026
Figure 5: Prostate Cancer Patient Flow in Europe, 2017
Figure 6: Prostate Cancer Patient Flow Forecast in Europe, 2017 - 2026
Figure 7: Prostate Cancer Patient Flow in Germany, 2017
Figure 8: Prostate Cancer Patient Flow Forecast in Germany, 2017 - 2026
Figure 9: Prostate Cancer Patient Flow in France, 2017
Figure 10: Prostate Cancer Patient Flow Forecast in France, 2017 - 2026
Figure 11: Prostate Cancer Patient Flow in Spain, 2017
Figure 12: Prostate Cancer Patient Flow Forecast in Spain, 2017 - 2026
Figure 13: Prostate Cancer Patient Flow in Italy, 2017
Figure 14: Prostate Cancer Patient Flow Forecast in Italy, 2017 - 2026
Figure 15: Prostate Cancer Patient Flow in UK, 2017
Figure 16: Prostate Cancer Patient Flow Forecast in UK, 2017 - 2026
Figure 17: Prostate Cancer Patient Flow in Japan, 2017
Figure 18: Prostate Cancer Patient Flow Forecast in Japan, 2017 - 2026
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll